METiS BioTech announces China's First AI-Enabled Formulation Drug Candidate to Complete Phase III Clinical Trial MTS-004 Poised to Fill an Unmet Need in the Treatment of Pseudobulbar… CISION PRNewswireOctober 23, 2025
Press Release Dreame's Sparkling Water Refrigerator Honored with Japan Good Design Award SUZHOU, China, Oct. 23, 2025 /PRNewswire/ — Dreame Technology’s innovative Sparkling Water… CISION PRNewswireOctober 23, 2025
Rescale Expands Digital Engineering Platform with the Launch of Data Intelligence for the AI Era New engineering data intelligence capabilities unlock R&D knowledge to boost efficiency and… CISION PRNewswireOctober 23, 2025
MCO (MyComplianceOffice) Rises to #42 in the Chartis RiskTech100 2026 NEW YORK, Oct. 23, 2025 /PRNewswire/ — MCO (MyComplianceOffice) has advanced to #42… CISION PRNewswireOctober 23, 2025
Gamehaus Holdings Inc. Files Annual Report on Form 20-F for Fiscal Year 2025 SHANGHAI, Oct. 23, 2025 /PRNewswire/ — Gamehaus Holdings Inc. ("Gamehaus" or the… CISION PRNewswireOctober 23, 2025
High-Trend International Group Announces Operational Adjustments in Response to U.S.- China Port Fee Policy SINGAPORE, Oct. 23, 2025 /PRNewswire/ — High-Trend International Group (the "Registrant" or… CISION PRNewswireOctober 23, 2025
IMG Announces 2025 Leave Your Mark Grant Winners INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ — IMG (International Medical Group) is excited to announce… CISION PRNewswireOctober 23, 2025
Press Release BingX Launches Zero-Fee Trading for BTC, ETH and BNB with Daily Rewards PANAMA CITY, Oct. 23, 2025 /PRNewswire/ — BingX, a leading cryptocurrency exchange… CISION PRNewswireOctober 23, 2025
